Effects of antipsychotics with diverse dopamine D2 and serotonin 5-HT1A properties on cerebral dopamine and serotonin levels in rats

被引：0
|
作者：
Assié, M
Ravailhe, V
Faucillon, V
Newman-Tancredi, A
机构：
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S438 / S438
页数：1
相关论文
共 50 条
  • [31] Hetero-dimerization of serotonin 5-HT2A and dopamine D2 receptors
    Lukasiewicz, Sylwia
    Polit, Agnieszka
    Kendracka-Krok, Sylwia
    Wedzony, Krzysztof
    Mackowiak, Marzena
    Dziedzicka-Wasylewska, Marta
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2010, 1803 (12): : 1347 - 1358
  • [32] Serotonin, serotonin 5-HT1A receptors and dopamine in blood peripheral lymphocytes of major depression patients
    Fajardo, O
    Galeno, J
    Urbina, M
    Carreira, I
    Lima, L
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2003, 3 (09) : 1345 - 1352
  • [33] Altered serotonin and dopamine metabolism in the CNS of serotonin 5-HT1A or 5-HT1B receptor knockout mice
    Ase, AR
    Reader, TA
    Hen, R
    Riad, M
    Descarries, L
    JOURNAL OF NEUROCHEMISTRY, 2000, 75 (06) : 2415 - 2426
  • [34] Structural analogues of 5-OMe-BPAT:: Synthesis and interactions with dopamine D2, D3, and serotonin 5-HT1A receptors
    Homan, EJ
    Kroodsma, E
    Copinga, S
    Unelius, L
    Mohell, N
    Wikström, HV
    Grol, CJ
    BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (06) : 1111 - 1121
  • [35] Effects of clozapine on the efflux of serotonin and dopamine in the rat brain:: the role of 5-HT1A receptors
    Hagino, Y
    Watanabe, M
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2002, 80 (12) : 1158 - 1166
  • [36] SLV313 is a dopamine D2 receptor antagonist and serotonin 5-HT1A receptor agonist:: In vitro and in vivo neuropharmacology
    Glennon, J
    McCreary, AC
    Ronken, E
    Siarey, R
    Hesselink, MB
    Feenstra, R
    Van Vliet, B
    Long, SK
    Kruse, CG
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S277 - S277
  • [37] Bifeprunox:: A novel atypical antipsychotic sharing dopamine D2 receptor partial agonism and serotonin 5-HT1A receptor agonism
    Marquis, KL
    Hertel, P
    Reindeers, JH
    van der Neut, M
    Ronken, E
    Hesselink, MB
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 305 - 305
  • [38] Dual Ligands Targeting Dopamine D2 and Serotonin 5-HT1A Receptors as New Antipsychotical or Anti-Parkinsonian Agents
    Ye, Na
    Song, Zilan
    Zhang, Ao
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (04) : 437 - 457
  • [39] C5-substituted derivatives of 5-OMe-BPAT:: Synthesis and interactions with dopamine D2 and serotonin 5-HT1A receptors
    Homan, EJ
    Tulp, MTM
    Nilsson, JE
    Wikström, HV
    Grol, CJ
    BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (11) : 2541 - 2548
  • [40] Novel, highly potent and selective serotonin 5-HT2A/dopamine D2 receptor antagonists as potential antipsychotics.
    Lee, TK
    Robichaud, AJ
    Boyle, KE
    Lu, YM
    Chen, WT
    McClung, C
    Deng, W
    Miller, KJ
    McElroy, JF
    Largent, BL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U17 - U17
12345